Status:
COMPLETED
Quality Control of CE-Certified Phonak Hearing Aids - 2020_43
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated ma...
Detailed Description
The study will compare different features of the Phonak behind the ear device activated and deactivated, for example the noise reduction feature. There shall be differences in listening effort, awaren...
Eligibility Criteria
Inclusion
- Adult hearing impaired persons (minimum age: 18 years, severe to profound Hearing loss)
- Good written and spoken (Swiss) German language skills
- Healthy outer ear
- Ability to fill in a questionnaire (p/eCRF) conscientiously
- willingness to wear Behind-the-ear hearing aids
- Informed Consent as documented by signature
Exclusion
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments in Stäfa (Switzerland)
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Known psychological problems
Key Trial Info
Start Date :
December 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 7 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04723173
Start Date
December 7 2020
End Date
June 7 2021
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonova AG
Stäfa, Canton of Zurich, Switzerland, 8712